The National Cancer Institute Annual Report to the Nation found cancer death rates continue to drop
On Sept. 6, 2006, a report from the nation’s leading cancer organizations found that Americans’ risk of dying…
National Cancer Institute researchers developed a new model for estimating the 5-year risk of melanoma
On Sept. 1, 2006, National Cancer Institute researchers developed a new model for estimating the 5-year risk of…
National Cancer Institute researchers discovered unique pattern of gene activity that predict liver cancer spread
On Aug. 14, 2006, National Cancer Institute (NCI) researchers announced they had found a unique pattern of activity…
Eli Lilly and Company’s Gemzar was approved for use in the treatment of women living with recurrent ovarian cancer
On Jul. 17, 2006, Eli Lilly and Company’s Gemzar was approved for use in the treatment of women…
The FDA approved the vaccine Gardasil for HPV
On Jun. 8, 2006, the FDA approved the vaccine Gardasil, which protects against persistent infection by the two…
Personalized treatment trial for breast cancer was launched
On May 23, 2006, the Trial Assigning IndividuaLized Options for Treatment (Rx), or TAILORx, was launched to examine…
Massey Cancer Center’s opened Goodwin Research Laboratory
On May 11, 2006, Massey Cancer Center’s opened Goodwin Research Laboratory, an 80,000-square-foot, state-of-the-art cancer research laboratory.
Osteoporosis drug shown to be as effective as Tamoxifen in preventing invasive breast cancer
On Apr. 17, 2006, the National Cancer Institute announced initial results of the Study of Tamoxifen and Raloxifene,…
Biotechnology | Diagnostics | Life Science News | NIH | Non-Profit Research | Oncology | Therapeutics
Siteman Cancer Center was selected to be part of the National Comprehensive Cancer Network
On Mar. 22, 2006, the Siteman Cancer Center at Barnes-Jewish Hospital and Washington School of Medicine in St….
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Therapeutics
Fred Hutchinson Cancer Research Center Joined Livestrong™ Survivorship Center of Excellence Network
On Mar. 20, 2006, the Fred Hutchinson Cancer Research Center announced that it had joined the Lance Armstrong…
NCI launched TAILORx trial to determine whether gene expression patterns in early-stage breast cancer can distinguish women at high risk of recurrence
In 2006, the NCI launched the TAILORx trial to determine whether gene expression patterns in early-stage breast cancer…
The prevalence of U.S. adult smoking declined to 20.8 percent in 2006
In 2006, an estimated 20.8% (45.3 million) of U.S. adults were current cigarette smokers; of these, 80.1% (36.3…
Yale New Haven Hospital broke ground for the new cancer hospital, scheduled to open in 2009
In 2006, Yale New Haven Hospital broke ground for the new cancer hospital, scheduled to open in 2009.
The Indiana University Cancer Center renamed Indiana University Melvin and Bren Simon Cancer Center
In 2006, The Indiana University Cancer Center was renamed the Indiana University Melvin and Bren Simon Cancer Center….
Calistoga Pharmaceuticals was founded
In 2006, Calistoga Pharmaceuticals was founded as a Seattle-based spin-off from ICOS Corp. that was dedicated to developing…
NCI and NHGRI launched effort to accelerate understanding molecular basis of cancer with genome analysis
On Dec. 13, 2005, the National Cancer Institute and the National Human Genome Research Institute launched a comprehensive…
Studies validated a new test can predict risk of breast cancer recurrence in a sizable group of patients
On Dec. 7, 2005, results from several studies presented at the San Antonio Breast Cancer Symposium validated that…
Karmanos Cancer Institute became Michigan’s first and only independent hospital exclusively for cancer patients
On Dec. 1, 2005, the Barbara Ann Karmanos Cancer Institute became Michigan’s first and only independent hospital exclusively…
National Cancer Institute launched a cancer biorepository pilot project to standardize biospecimen collection
On Nov. 7, 2005, the National Cancer Institute launched a cancer biorepository pilot project designed to standardize biospecimen…
Preliminary results from the Digital vs Film Mammographic Imaging Screening Trial showed no difference in breast cancer detection
On Oct. 27, 2005, preliminary results from the Digital vs. Film Mammographic Imaging Screening Trial showed no difference…
The National Cancer Institute announced the Transdisciplinary Research on Energetics and Cancer initiative
On Oct. 11, 2005, the National Cancer Institute announced the Transdisciplinary Research on Energetics and Cancer (TREC) initiative…
Biotechnology | Diagnostics | Disease | Life Science News | NIH | Non-Profit Research | Oncology | Therapeutics
Annual Report to the Nation on the Status of Cancer showed cancer death rates dropped from 1993-2002
On Oct. 5, 2005, the National Cancer Institute’s Annual Report to the Nation on the Status of Cancer,…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Siteman Cancer Center opened a new center at Barnes-Jewish St Peters Hospital
On Sept. 22, 2005, the Siteman Cancer Center opened a new center at Barnes-Jewish St. Peters Hospital. The…
Preliminary results from clinical trial of digital vs film mammography showed no difference in breast cancer detection
On Sept. 16, 2005, preliminary results from a large, clinical trial of digital vs. film mammography showed no…
The National Cancer Institute approved a $10 million award for OHSU Cancer Institute
On Jul. 18, 2005, Oregon Health & Science University (OHSU) announced receipt of a five-year, $10 million award…
Biotechnology | Disease | NIH | Therapeutics
The Patient Navigator Outreach and Chronic Disease Prevention Act amended the Public Health Service Act
On Jun. 29, 2005, the Patient Navigator Outreach and Chronic Disease Prevention Act of 2005 (P.L. 109-18) amended…
The National Cancer Institute announced the Community Networks Program
On May 6, 2005, the National Cancer Institute announced the Community Networks Program (CNP), a 5-year initiative to…
Karmanos Cancer Institute acquired clinical facilities from the Detroit Medical Center
On May 1, 2005, The Wayne State University Karmanos Cancer Institute announced it had acquired its clinical facilities…
NCI-sponsored clinical trials showed patients with early-stage, HER2-positive, invasive breast cancer experienced decrease in risk of cancer recurrence
On Apr. 27, 2005, results from two large NCI-sponsored randomized clinical trials showed that patients with early-stage, HER2-positive,…
NCI trial reported targeted agent trastuzumab and standard chemo cut risk of HER-2-positive breast cancer
On Apr. 25, 2005, the combination of the targeted agent trastuzumab (Herceptin) and standard chemotherapy cuts the risk…